These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 20955457
1. Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy. Heikkilä A, Siironen P, Hagström J, Heiskanen I, Sankila R, Louhimo J, Haglund C, Arola J. APMIS; 2010 Nov; 118(11):846-54. PubMed ID: 20955457 [Abstract] [Full Text] [Related]
2. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [Abstract] [Full Text] [Related]
3. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML. Am J Surg Pathol; 1999 Jun; 23(6):678-85. PubMed ID: 10366150 [Abstract] [Full Text] [Related]
4. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV. Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277 [Abstract] [Full Text] [Related]
5. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma. Troncone G, Iaccarino A, Russo M, Palmieri EA, Volante M, Papotti M, Viglietto G, Palombini L. J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934 [Abstract] [Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [Abstract] [Full Text] [Related]
7. An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland. Goto A, Sakamoto A, Machinami R. Pathol Res Pract; 2001 May; 197(4):217-22. PubMed ID: 11358005 [Abstract] [Full Text] [Related]
8. [Thyroidal oxyphilic tumors]. Sabo R, Zohar Y, Schwartz A, Segal K. Harefuah; 1994 Feb 15; 126(4):183-6, 240. PubMed ID: 8168757 [Abstract] [Full Text] [Related]
9. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM, Adabi Kh, Lashkari A, Heshmat R, Haghpanah V, Larijani B, Tavangar SM. Pathol Res Pract; 2009 Feb 15; 205(2):83-7. PubMed ID: 18996649 [Abstract] [Full Text] [Related]
10. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Oestreicher-Kedem Y, Halpern M, Roizman P, Hardy B, Sulkes J, Feinmesser R, Stern Y. Head Neck; 2004 Nov 15; 26(11):960-6. PubMed ID: 15386597 [Abstract] [Full Text] [Related]
11. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z. Diagn Cytopathol; 2004 Nov 15; 31(5):307-12. PubMed ID: 15468114 [Abstract] [Full Text] [Related]
12. Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015. Glomski K, Nosé V, Faquin WC, Sadow PM. Endocr Pathol; 2017 Jun 15; 28(2):177-185. PubMed ID: 28444500 [Abstract] [Full Text] [Related]
13. New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms. Cameselle-Teijeiro JM, Sobrinho-Simões M. Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar 15; 65(3):133-135. PubMed ID: 29396216 [No Abstract] [Full Text] [Related]
14. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Buergy D, Weber T, Maurer GD, Mudduluru G, Medved F, Leupold JH, Brauckhoff M, Post S, Dralle H, Allgayer H. Int J Cancer; 2009 Aug 15; 125(4):894-901. PubMed ID: 19480010 [Abstract] [Full Text] [Related]
15. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Pulcrano M, Boukheris H, Talbot M, Caillou B, Dupuy C, Virion A, De Vathaire F, Schlumberger M. Thyroid; 2007 Jul 15; 17(7):639-46. PubMed ID: 17696834 [Abstract] [Full Text] [Related]
16. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors. Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Satacińska-Los E, Kulig A, Włoch J. Pol J Pathol; 2005 Jul 15; 56(1):27-35. PubMed ID: 15921011 [Abstract] [Full Text] [Related]
17. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M. Hum Pathol; 2008 Nov 15; 39(11):1656-63. PubMed ID: 18657294 [Abstract] [Full Text] [Related]
18. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm. Covach A, Patel S, Hardin H, Lloyd RV. Endocr Pathol; 2017 Sep 15; 28(3):207-212. PubMed ID: 28660408 [Abstract] [Full Text] [Related]
19. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas. Yegen G, Altay AY, Yılmaz İ, İşcan Y, Sormaz İC, Aksakal N, Önder S, Mete Ö. Endocr Pathol; 2023 Sep 15; 34(3):279-286. PubMed ID: 37574466 [Abstract] [Full Text] [Related]
20. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, Torchio B, Papotti MG. Cancer; 2004 Mar 01; 100(5):950-7. PubMed ID: 14983490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]